Kulbe Hagen, Levinson Neil R, Balkwill Fran, Wilson Julia L
Cancer Research UK, Translational Oncology Laboratory, Queen Mary's School of Medicine and Dentistry, London EC1M 6BQ, UK.
Int J Dev Biol. 2004;48(5-6):489-96. doi: 10.1387/ijdb.041814hk.
Cytokine and chemokine gradients are central to the directed movement of cells in both homeostatic and pathological processes. Most cancers have a complex chemokine network which can influence immune responses to the tumor, direct the extent and cellular composition of the leukocyte infiltrate and also play a role in angiogenesis. Tumor cells can also hijack the chemokine system and gain expression of certain chemokine receptors and respond to specific chemokine gradients. Chemokine receptor expression and activation on malignant cells may be central to the growth, survival and migration of cancer cells from the primary tumor. Chemokine receptors, both CC and CXC have been detected on malignant cells and the relevant ligands are sometimes expressed at the tumor site and at sites of tumor spread, suggesting a role for the chemokine family in malignant growth and metastasis.
细胞因子和趋化因子梯度对于细胞在稳态和病理过程中的定向移动至关重要。大多数癌症都有一个复杂的趋化因子网络,它可以影响对肿瘤的免疫反应,指导白细胞浸润的程度和细胞组成,并且在血管生成中也发挥作用。肿瘤细胞还可以利用趋化因子系统,获得某些趋化因子受体的表达,并对特定的趋化因子梯度作出反应。恶性细胞上趋化因子受体的表达和激活可能对于癌细胞从原发性肿瘤的生长、存活和迁移至关重要。在恶性细胞上已检测到CC和CXC趋化因子受体,相关配体有时在肿瘤部位和肿瘤转移部位表达,这表明趋化因子家族在恶性生长和转移中发挥作用。